ALNYLAM PHARMACEUTICALS, INC. - COM (ALNY)

Q4 2018 13F Portfolio Holders as of 12/31/2018

Type / Class
Equity / COM
Number of holders
272
Total Shares
92.3M
Shares change
+1.79M
Total reported value, excl. options
$6.73B
Value change
+$108M
Put/Call ratio
0.42
Number of buys
126
Number of sells
-142
Price
$72.91
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.